Literature DB >> 10202172

Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy.

G M Thomas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202172     DOI: 10.1056/NEJM199904153401509

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  62 in total

1.  [Simultaneous radiochemotherapy with cisplatin improves survival in cervical cancer].

Authors:  J Dunst; R Sauer
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  Accelerated publication versus usual publication in 2 leading medical journals.

Authors:  William A Ghali; Jacques Cornuz; Finlay A McAlister; Jean-Blaise Wasserfallen; P J Devereaux; C David Naylor
Journal:  CMAJ       Date:  2002-04-30       Impact factor: 8.262

3.  Concurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial.

Authors:  Z Li; W Mao; N Lin; S Han
Journal:  Clin Transl Oncol       Date:  2015-08-25       Impact factor: 3.405

4.  Antitumor activity of a polysaccharide fraction from Laminaria japonica on U14 cervical carcinoma-bearing mice.

Authors:  Qingzhi Zhai; Xiuli Li; Yizhuo Yang; Ling Yu; Yuanqing Yao
Journal:  Tumour Biol       Date:  2013-08-08

5.  Prospective randomized study comparing concomitant chemoradiotherapy using weekly cisplatin & paclitaxel versus weekly cisplatin in locally advanced carcinoma cervix.

Authors:  Pragyat Thakur; Rajeev Seam; Manoj Gupta; Manish Gupta
Journal:  Ann Transl Med       Date:  2016-02

6.  Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.

Authors:  Yoshiko Ueno; Robert Lisbona; Tsutomu Tamada; Amer Alaref; Kazuro Sugimura; Caroline Reinhold
Journal:  Br J Radiol       Date:  2017-06-16       Impact factor: 3.039

7.  MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway.

Authors:  Juan Du; LiNa Wang; ChenXi Li; HuiLun Yang; YuanBo Li; Haiyang Hu; Hui Li; ZongFeng Zhang
Journal:  Tumour Biol       Date:  2015-10-19

8.  Green synthesis of bimetallic Au@Pt nanostructures and their application for proliferation inhibition and apoptosis induction in human cervical cancer cell.

Authors:  Ali A Alshatwi; Jegan Athinarayanan; Vaiyapuri Subbarayan Periasamy
Journal:  J Mater Sci Mater Med       Date:  2015-03-13       Impact factor: 3.896

9.  Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects.

Authors:  Sung Yong Lee; Tae Heung Kang; Jayne Knoff; Zhuomin Huang; Ruey-Shyang Soong; Ronald D Alvarez; Chien-Fu Hung; T-C Wu
Journal:  Cancer Immunol Immunother       Date:  2013-04-25       Impact factor: 6.968

10.  Radiotherapy dose escalation with concurrent chemotherapy in locally advanced cervix cancer is feasible.

Authors:  M W Hegazy; R I Mahmood; I A Al-Badawi; B Moftah; H AlHusaini
Journal:  Clin Transl Oncol       Date:  2015-07-10       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.